Literature DB >> 32169912

OpenDose: Open-Access Resource for Nuclear Medicine Dosimetry.

Maxime Chauvin1, Damian Borys2, Francesca Botta3, Pawel Bzowski2, Jérémie Dabin4, Ana M Denis-Bacelar5, Aurélie Desbrée6, Nadia Falzone7,8, Boon Quan Lee7,8, Andrea Mairani9,10, Alessandra Malaroda11,12, Gilles Mathieu13, Erin McKay14, Erick Mora-Ramirez1,15, Andrew P Robinson5,16,17, David Sarrut, Lara Struelens4, Alex Vergara Gil1, Manuel Bardiès18.   

Abstract

Radiopharmaceutical dosimetry depends on the localization in space and time of radioactive sources and requires the estimation of the amount of energy emitted by the sources deposited within targets. In particular, when computing resources are not accessible, this task can be performed using precomputed tables of specific absorbed fractions (SAFs) or S values based on dosimetric models. The aim of the OpenDose collaboration is to generate and make freely available a range of dosimetric data and tools.
Methods: OpenDose brings together resources and expertise from 18 international teams to produce and compare traceable dosimetric data using 6 of the most popular Monte Carlo codes in radiation transport (EGSnrc/EGS++, FLUKA, GATE, Geant4, MCNP/MCNPX, and PENELOPE). SAFs are uploaded, together with their associated statistical uncertainties, in a relational database. S values are then calculated from monoenergetic SAFs on the basis of the radioisotope decay data presented in International Commission on Radiological Protection Publication 107.
Results: The OpenDose collaboration produced SAFs for all source region and target combinations of the 2 International Commission on Radiological Protection Publication 110 adult reference models. SAFs computed from the different Monte Carlo codes were in good agreement at all energies, with SDs below individual statistical uncertainties. Calculated S values were in good agreement with OLINDA/EXM 2.0 (commercial) and IDAC-Dose 2.1 (free) software. A dedicated website (www.opendose.org) has been developed to provide easy and open access to all data.
Conclusion: The OpenDose website allows the display and downloading of SAFs and the corresponding S values for 1,252 radionuclides. The OpenDose collaboration, open to new research teams, will extend data production to other dosimetric models and implement new free features, such as online dosimetric tools and patient-specific absorbed dose calculation software, together with educational resources.
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  Monte Carlo methods; dosimetry; nuclear medicine; open-access database

Mesh:

Year:  2020        PMID: 32169912      PMCID: PMC7539649          DOI: 10.2967/jnumed.119.240366

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  17 in total

1.  History by history statistical estimators in the BEAM code system.

Authors:  B R B Walters; I Kawrakow; D W O Rogers
Journal:  Med Phys       Date:  2002-12       Impact factor: 4.071

2.  The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103.

Authors: 
Journal:  Ann ICRP       Date:  2007

3.  ICRP Publication 107. Nuclear decay data for dosimetric calculations.

Authors:  K Eckerman; A Endo
Journal:  Ann ICRP       Date:  2008

Review 4.  A review of the use and potential of the GATE Monte Carlo simulation code for radiation therapy and dosimetry applications.

Authors:  David Sarrut; Manuel Bardiès; Nicolas Boussion; Nicolas Freud; Sébastien Jan; Jean-Michel Létang; George Loudos; Lydia Maigne; Sara Marcatili; Thibault Mauxion; Panagiotis Papadimitroulas; Yann Perrot; Uwe Pietrzyk; Charlotte Robert; Dennis R Schaart; Dimitris Visvikis; Irène Buvat
Journal:  Med Phys       Date:  2014-06       Impact factor: 4.071

Review 5.  An exponential growth of computational phantom research in radiation protection, imaging, and radiotherapy: a review of the fifty-year history.

Authors:  X George Xu
Journal:  Phys Med Biol       Date:  2014-08-21       Impact factor: 3.609

6.  RADAR Dose Estimate Report: A Compendium of Radiopharmaceutical Dose Estimates Based on OLINDA/EXM Version 2.0.

Authors:  Michael G Stabin; Jeffry A Siegel
Journal:  J Nucl Med       Date:  2017-09-08       Impact factor: 10.057

7.  New mesh-type phantoms and their dosimetric applications, including emergencies.

Authors:  C H Kim; Y S Yeom; T T Nguyen; M C Han; C Choi; H Lee; H Han; B Shin; J-K Lee; H S Kim; M Zankl; N Petoussi-Henss; W E Bolch; C Lee; B S Chung; R Qiu; K Eckerman
Journal:  Ann ICRP       Date:  2018-04-13

8.  IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms.

Authors:  Martin Andersson; Lennart Johansson; Keith Eckerman; Sören Mattsson
Journal:  EJNMMI Res       Date:  2017-11-03       Impact factor: 3.138

9.  Dosimetry-based treatment planning for molecular radiotherapy: a summary of the 2017 report from the Internal Dosimetry Task Force.

Authors:  Caroline Stokke; Pablo Minguez Gabiña; Pavel Solný; Francesco Cicone; Mattias Sandström; Katarina Sjögreen Gleisner; Carlo Chiesa; Emiliano Spezi; Maria Paphiti; Mark Konijnenberg; Matt Aldridge; Jill Tipping; Michael Wissmeyer; Boudewijn Brans; Klaus Bacher; Carsten Kobe; Glenn Flux
Journal:  EJNMMI Phys       Date:  2017-11-21

10.  EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations.

Authors:  Jonathan I Gear; Maurice G Cox; Johan Gustafsson; Katarina Sjögreen Gleisner; Iain Murray; Gerhard Glatting; Mark Konijnenberg; Glenn D Flux
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-14       Impact factor: 9.236

View more
  6 in total

1.  Patient-specific dosimetry adapted to variable number of SPECT/CT time-points per cycle for [Formula: see text]Lu-DOTATATE therapy.

Authors:  Laure Vergnaud; Anne-Laure Giraudet; Aurélie Moreau; Julien Salvadori; Alessio Imperiale; Thomas Baudier; Jean-Noël Badel; David Sarrut
Journal:  EJNMMI Phys       Date:  2022-05-16

Review 2.  Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.

Authors:  Valentina Ambrosini; Jolanta Kunikowska; Eric Baudin; Lisa Bodei; Catherine Bouvier; Jaume Capdevila; Marta Cremonesi; Wouter W de Herder; Clarisse Dromain; Massimo Falconi; Melpomeni Fani; Stefano Fanti; Rodney J Hicks; Levent Kabasakal; Gregory Kaltsas; Val Lewington; Silvia Minozzi; Michela Cinquini; Kjell Öberg; Wim J G Oyen; Dermot O'Toole; Marianne Pavel; Philippe Ruszniewski; Aldo Scarpa; Jonathan Strosberg; Anders Sundin; David Taïeb; Irene Virgolini; Damian Wild; Ken Herrmann; James Yao
Journal:  Eur J Cancer       Date:  2021-02-12       Impact factor: 9.162

3.  Selection of the First 99mTc-Labelled Somatostatin Receptor Subtype 2 Antagonist for Clinical Translation-Preclinical Assessment of Two Optimized Candidates.

Authors:  Melpomeni Fani; Viktoria Weingaertner; Petra Kolenc Peitl; Rosalba Mansi; Raghuvir H Gaonkar; Piotr Garnuszek; Renata Mikolajczak; Doroteja Novak; Urban Simoncic; Alicja Hubalewska-Dydejczyk; Christine Rangger; Piriya Kaeopookum; Clemens Decristoforo
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-28

Review 4.  Personalized Dosimetry in Targeted Radiation Therapy: A Look to Methods, Tools and Critical Aspects.

Authors:  Rachele Danieli; Alessia Milano; Salvatore Gallo; Ivan Veronese; Alessandro Lascialfari; Luca Indovina; Francesca Botta; Mahila Ferrari; Alessandro Cicchetti; Davide Raspanti; Marta Cremonesi
Journal:  J Pers Med       Date:  2022-02-02

5.  EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands.

Authors:  Katarina Sjögreen Gleisner; Nicolas Chouin; Pablo Minguez Gabina; Francesco Cicone; Silvano Gnesin; Caroline Stokke; Mark Konijnenberg; Marta Cremonesi; Frederik A Verburg; Peter Bernhardt; Uta Eberlein; Jonathan Gear
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-03-14       Impact factor: 10.057

Review 6.  Individualization of Radionuclide Therapies: Challenges and Prospects.

Authors:  Hanna Piwowarska-Bilska; Sara Kurkowska; Bozena Birkenfeld
Journal:  Cancers (Basel)       Date:  2022-07-14       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.